loading
loading
Senores Pharmaceuticals shares fall 6% despite 22% rise in Q2 profit; revenue jumps 25% - Edited byAnshul - Published OnOct 29, 2026 | 14:43 IST - Last Updated OnOct 29, 2026 | 14:47 IST Senores Pharmaceuticals reported strong Q2 results with revenue up 24.7% and net profit rising 22.3%, despite its shares facing downward pressure. Senores Pharmaceuticals shares are under pressure after the company reported its results. In the quarter that ended in September, 2026, the pharma company recorded strong number with a rise in profit, revenue and profitability. The Ahmedabad-based pharmaceutical company’s net profit rose 22.3% year-on-year to ₹39.5 crore in the second quarter of FY27, compared with ₹32.3 crore in the corresponding period last year. Revenue increased 24.7% to ₹192 crore in Q2 FY27 from ₹154 crore a year earlier. Operating performance improved during the September quarter, with Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) rising by 39% year-on-year to ₹57 crore. In the previous cycle, the EBITDA stood at ₹41 crore. Furthemore, the EBITDA margin expanded to 30% in Q2 from 26.9% in the corresponding quarter last year, indicating an improvement of 310 basis points. The shares of Senores Pharmaceuticals have fallen over 6%, the stock despite slipping has made a minor recovery, while remaining in red. The shares have seen a rise of 41.63% in the past 6 months of trade. In the past 3 months however, the shares have seen a dip of nearly 3%. The stock price now stands at ₹1,283.20. Also Read: Tata Sons vs Tata Trusts: Why November is a crucial month for the Tata Group More from Market Ambuja Cements Q2 Results: Net profit plunges 90% year-on-year, misses estimate Oct 29, 2026 Apar Industries shares gain 5% after Q2 profit, EBITDA beat estimates, margins expand by 190 basis points Oct 29, 2026 Shadowfax Tech Q2 Results: Profit jumps five-fold as margin expand, revenue up 57% Oct 29, 2026
document fetched 2026-10-30 02:56 · canonical https://cnbctv18.com/market/senores-pharmaceuticals-shares-fall-rise-in-q2-profit-revenue-jumps-20022371.htm